logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9562039 B1

PDFFull Text
Expired
Date of Patent:
Feb. 07, 2017

Filed:

Feb. 27, 2014

Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities

Applicant:

Almirall, S.a., Barcelona, ES;

Inventors:

Montserrat Julia Jane, Barcelona, ES;

Francesc Carrera Carrera, Barcelona, ES;

Maria Prat Quiñones, Barcelona, ES;

Carlos Puig Duran, Barcelona, ES;

Francesca Pajuelo Lorenzo, Barcelona, ES;

Juan Antonio Perez Andres, Barcelona, ES;

Assignee:

Almirall, S.A., Barcelona, ES;

Attorney:

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Primary Examiner:

D M Seaman

Int. Cl.
CPC ...
C07D 409/14 (2006.01); A61K 31/4709 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); C07C 59/255 (2006.01); C07C 309/05 (2006.01); C07D 275/06 (2006.01);
U.S. Cl.
CPC ...
C07D 409/14 (2013.01); A61K 9/0073 (2013.01); A61K 9/0075 (2013.01); A61K 31/4709 (2013.01); A61K 45/06 (2013.01); C07C 59/255 (2013.01); C07C 309/05 (2013.01); C07D 275/06 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.

Find Patent Forward Citations

Julia Jane, Montserrat. (2017). Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities (U.S. Patent No. 9562039). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9562039

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…